Remove DEA Remove Legalization Remove Safety Remove Treatment
article thumbnail

Court: DEA Must Explain Its Failure to Act Upon Pending Marijuana Cultivation Applications

NORML

” To date, however, the agency has neither affirmed or denied any of the 26 applicants that have sought the DEA’s permission for a federal cultivation license. Read NORML’s new op-ed, “Three years ago the DEA said they would remove roadblocks to cannabis research — they still haven’t, here.).

DEA 227
article thumbnail

DEA Approves Cocaine Derivative for Parkinson’s Research. Why Not Cannabis?

Veriheal

But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. After receiving a petition three years prior, the DEA finally answered with action, making plans to deschedule [18F]FP-CIT , a controlled substance derived from cocaine.

DEA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Colorado Could Legalize Psychedelics This November

Veriheal

Colorado could legalize psychedelics. These include legalizing the possession, cultivation, use, and sharing of psychedelic components such as ibogaine , mescaline , DMT, psilocybin , and psilocin for adults over the age of 21. The city of Denver, Colorado, decriminalized the possession and use of psilocybin in 2019—the first U.S.

article thumbnail

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

Though it doesn’t get users high like THC-dominant products, CBD is all the rage these days due to its medical benefits and gray-area legality. On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances.

DEA 51
article thumbnail

Harvard Law Review: Patents on Psychedelics: The Next Legal Battlefront of Drug Development

Cannabis Law Report

This Essay analyzes the ethical, legal, and social implications of patenting these controversial substances. Controlled Substance Schedules , DRUG ENF’T ADMIN., [link] [ [link] ] (defining DEA criteria for categorization in Schedule I and listing psychedelic examples such as lysergic acid diethylamide (LSD), peyote, and MDMA).

article thumbnail

Senators Call For Report On State Of Psychedelic Research

Cannabis Law Report

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2020, Oregon became the first locale to decriminalize psilocybin and legalize it for therapeutic use on a statewide basis. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8]

article thumbnail

Psilocybin-Alcohol Study, FDA’s Psychedelic Guide, & the NCAA’s Cannabis Overhaul Begins

Veriheal

Additionally, participants also reported feeling increased self-awareness and general improvement in relationships following their treatment. The document also addresses study participant safety emphasizing how psychedelics’ psychoactive effects increase the potential for abuse.